Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Smokey1958on Sep 16, 2024 3:51pm
164 Views
Post# 36226009

RE:THRM always lower constant up to 0.03¢ or 0.045¢

RE:THRM always lower constant up to 0.03¢ or 0.045¢

Timbre - the quality of a sound (or a post in this case). Is it $.03, $.045, $.05 or $.055? Why did you leave out $.035 and $.04??? 

Significant news will be out soon enough as the stock passes the October 1st date of code eligibility. It will probably take a month after that to get a sense of how well Venowave will be marketed and sold. Most reviews of the product, the addition of some well healed advisors and a generous offering in terms of cost coverage suggest a fantastic close to 2024.

What does your crystal ball suggest?

<< Previous
Bullboard Posts
Next >>